T Maier
University of Zurich
10 Papers
197 Citations
T Maier is an academic researcher from University of Zurich. The author has contributed to research in topics: Melanoma & Basal cell carcinoma. The author has an hindex of 8, co-authored 10 publications.
Chat about Author
Papers
Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy.
Lucie Heinzerling,Günter Burg,Reinhard Dummer,T Maier,Patrick A. Oberholzer,Jan Schultz,Lina Elzaouk,Jovan Pavlovic,Karin Moelling +8 more
TL;DR: Results show that intratumoral injection of DNA produced some beneficial clinical effect against various human cancers, and patients, in particular the clinical and local responders, exhibited an antigen-specific immune response against MAGE-1 and MART-1, which in some cases preexisted.
164
Mechanisms Underlying Imiquimod-Induced Regression of Basal Cell Carcinoma In Vivo
TL;DR: Tumor cells became more susceptible to apoptosis through decreased Bcl-2 expression after treatment with 5% imiquimod cream, and induced a massive increase in macrophage peritumoral and intratumoral infiltration.
145
Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells
T Maier,Adrian Tun-Kyi,Anatoli Tassis,Karl-Peter Jungius,Guenter Burg,Reinhard Dummer,Frank O. Nestle +6 more
TL;DR: Intranodal injection of autologous tumor-lysate-pulsed DCs is well-tolerated and achieves immunologic and objective clinical responses in selected CTCL patients.
135
Survival and prognostic factors in patients with brain metastases from malignant melanoma.
TL;DR: Treatment with temozolomide will possibly play an important role in the future management of patients with brain metastases from cutaneous melanoma, but further prospective studies are urgently needed.
Imiquimod Treatment Induces Expression of Opioid Growth Factor Receptor: A Novel Tumor Antigen Induced by Interferon-α?
Mirjana Urosevic,Patrick A. Oberholzer,T Maier,Jürg Hafner,Elisabeth Laine,Herbert Slade,Bernd Benninghoff,Günter Burg,Reinhard Dummer +8 more
TL;DR: In addition to its immunomodulatory and antiproliferative activity, opioid growth factor receptor seems to have a prognostic significance in basal cell carcinoma patients.
60